Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma is an aggressive non-Hodgkin's lymphoma without a standard therapy for patients who relapse after or are not eligible for salvage autologous stem cell transplantation. In vitro analysis of lymphoma cell lines has shown that everolimus can inhibit cell cycle progres...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Barnes, Jeffrey A., Jacobsen, Eric, Feng, Yang, Freedman, Arnold, Hochberg, Ephraim P., LaCasce, Ann S., Armand, Philippe, Joyce, Robin, Sohani, Aliyah R., Rodig, Scott J., Neuberg, Donna, Fisher, David C., Abramson, Jeremy S.
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2013
Matèries:
Original Articles and Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3659994/
https://ncbi.nlm.nih.gov/pubmed/23144193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.075184
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars